Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Regular monitoring, quick intervention, and lifestyle changes make all the difference
European Medicines Agency (EMA) (2025) EMA concludes review of weight management medicine Mysimba (naltrexone/bupropion)
Medical Conditions That May Qualify You If your BMI is between 27-29.9, you may still qualify for GLP-1 medications if you have: Type 2 diabetes or prediabetes High blood pressure (hypertension) High cholesterol or dyslipidemia Sleep apnea Cardiovascular disease Metabolic syndrome Insulin resistance These conditions are often interconnected with weight, and GLP-1 for weight loss can help address multiple health concerns simultaneously
This includes: Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Dulaglutide (Trulicity) Liraglutide (Saxenda) Most prescribing information suggests discontinuing these medications at least 2 months before attempting conception due to potential fetal harm observed in animal studies, including: Growth restriction Delayed skeletal development Increased pregnancy loss There is limited human data, but the risk signals are sufficient to justify a cautious, prevention-first approach
Email: [email protected] (GL)
